Gene · 779
Papers2,128
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,128
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Suspected malignant hyperthermia in a young Chinese patient undergoing a micro varicocelectomy surgery. | Chin Med J (Engl) | 2023 | 36939613 | PubTator, text mining | PubMed |
| Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk. | Nat Genet | 2023 | 36914875 | PubTator, text mining | PubMed |
| Challenges in the diagnosis and treatment of the malignant adnexal neoplasms of the head and neck. | Curr Opin Otolaryngol Head Neck Surg | 2023 | 36912226 | PubTator, text mining | PubMed |
| Cancer and Myotonic Dystrophy. | J Clin Med | 2023 | 36902726 | PubTator, text mining | PubMed |
| A Mutation in CACNA1S Is Associated with Multiple Supernumerary Cusps and Root Maldevelopment. | Diagnostics (Basel) | 2023 | 36900039 | PubTator, text mining | PubMed |
| Sarcoplasmic Reticulum Ca2+ Buffer Proteins: A Focus on the Yet-To-Be-Explored Role of Sarcalumenin in Skeletal Muscle Health and Disease. | Cells | 2023 | 36899851 | PubTator, text mining | PubMed |
| Non-coding RNA and arrhythmias: expression, function, and molecular mechanism. | Europace | 2023 | 36881784 | PubTator, text mining | PubMed |
| Quantitative proteomic analysis of skeletal muscles from wild-type and transgenic mice carrying recessive Ryr1 mutations linked to congenital myopathies. | Elife | 2023 | 36862731 | PubTator, text mining | PubMed |
| Molecular mechanisms of atrazine toxicity on H19-7 hippocampal neurons revealed by integrated miRNA and mRNA "omics". | Ecotoxicol Environ Saf | 2023 | 36841081 | PubTator, text mining | PubMed |
| Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review. | Int J Mol Sci | 2023 | 36835142 | PubTator, text mining | PubMed |
| Impact of the Voltage-Gated Calcium Channel Antagonist Nimodipine on the Development of Oligodendrocyte Precursor Cells. | Int J Mol Sci | 2023 | 36835129 | PubTator, text mining | PubMed |
| Concomitant Calcium Channelopathies Involving CACNA1A and CACNA1F: A Case Report and Review of the Literature. | Genes (Basel) | 2023 | 36833327 | PubTator, text mining | PubMed |
| Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene. | Genes (Basel) | 2023 | 36833203 | PubTator, text mining | PubMed |
| Pharmacological Inhibition of Membrane Signaling Mechanisms Reduces the Invasiveness of U87-MG and U251-MG Glioblastoma Cells In Vitro. | Cancers (Basel) | 2023 | 36831372 | PubTator, text mining | PubMed |
| Endogenous and Exogenous Antioxidants in Skeletal Muscle Fatigue Development during Exercise. | Antioxidants (Basel) | 2023 | 36830059 | PubTator, text mining | PubMed |
| Structure of human NaV1.6 channel reveals Na+ selectivity and pore blockade by 4,9-anhydro-tetrodotoxin. | Nat Commun | 2023 | 36823201 | PubTator, text mining | PubMed |
The significant antidyslipidemic, hypoglycemic, antihyperglycemic, and antiobesity activities of the aqueous extracts of Agave Sisalana juice are partly mediated via modulation of calcium signaling pathways. | Heliyon | 2023 | 36816233 | PubTator, text mining | PubMed |
| Predicting gene knockout effects from expression data. | BMC Med Genomics | 2023 | 36803845 | PubTator, text mining | PubMed |
| Whole Exome Sequencing of Hemiplegic Migraine Patients Shows an Increased Burden of Missense Variants in CACNA1H and CACNA1I Genes. | Mol Neurobiol | 2023 | 36786913 | PubTator, text mining | PubMed |
| Gene panel analysis of 119 index patients with suspected periodic paralysis in Japan. | Front Neurol | 2023 | 36779057 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/779/papers?page=12